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Questions: In the active phase of the ﬁrst stage of labour, does transcutaneous electrical nerve
stimulation (TENS) relieve pain or change its location? Does TENS delay the request for neuraxial
analgesia during labour? Does TENS produce any harmful effects in themother or the foetus? Arewomen
in labour satisﬁed with the care provided? Design: Randomised trial with concealed allocation, assessor
blinding for some outcomes, and intention-to-treat analysis. Participants: Forty-six low-risk,
primigravida parturients with a gestational age > 37 weeks, cervical dilation of 4 cm, and without
the use of any medications from hospital admission until randomisation. Intervention: The principal
investigator applied TENS to the experimental group for 30 minutes starting at the beginning of the active
phase of labour. A second investigator assessed the outcomes in both the control and experimental
groups. Both groups received routine perinatal care.Outcomemeasures: The primary outcomewas pain
severity after the intervention period, which was assessed using the 100-mm visual analogue scale.
Secondary outcomes included: pain location, duration of the active phase of labour, time to
pharmacological labour analgesia, mode of birth, neonatal outcomes, and the participant’s satisfaction
with the care provided. Results: After the intervention, a signiﬁcant mean difference in change in pain of
15 mmwas observed [15_TD$DIFF]favouring the [16_TD$DIFF]experimental group (95% CI [17_TD$DIFF]2 to [18_TD$DIFF]27). The application of TENS did not
alter the location or distribution of the pain. The mean time to pharmacological analgesia after the
intervention was 5.0 hours (95% CI 4.1 to 5.9 [2_TD$DIFF]) longer in the experimental group. The intervention did not
signiﬁcantly impact the other maternal and neonatal outcomes. Participants in both groups were
satisﬁed with the care provided during labour. Conclusion: TENS produces a signiﬁcant decrease in pain
during labour and postpones the need for pharmacological analgesia for pain relief. Trial registration:
NCT01600495. [Santana LS, Gallo RBS, Ferreira CHJ, Duarte G, Quintana SM, Marcolin AC ( [19_TD$DIFF]2016)
Transcutaneous electrical nerve stimulation (TENS) reduces pain and postpones the need for
pharmacological analgesia during labour: a randomised trial. Journal of Physiotherapy 62: 29–34]
 2015 Published by Elsevier B.V. on behalf of Australian Physiotherapy Association. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Pain during labour is the most intense pain that many women
will experience during their lives, and it can be inﬂuenced not only
by the anatomical and physiological factors of the labouring
women, but also by their psychological experiences, as well as
cultural, social, and environmental factors.1–3 [14_TD$DIFF] Labour pain is
associated with adverse physiological consequences for the
parturient, the progress of labour, and the well-being of the
foetus. The potential effects of labour pain may include: increased
oxygen consumption and hyperventilation resulting in hypocarbia
and respiratory alkalosis, as well as stimulation of the autonomic
nervous system and catecholamine production, which causes
increased peripheral vascular resistance, cardiac output and blood
pressure; decreased placental perfusion; and [21_TD$DIFF]unco-ordinated
uterine activity.4,5 During labour, pain should always be relieved
in order to reduce its deleterious effects.http://dx.doi.org/10.1016/j.jphys.2015.11.002
1836-9553/ 2015 Published by Elsevier B.V. on behalf of Australian Physiotherapy A
creativecommons.org/licenses/by-nc-nd/4.0/).Neuraxial analgesia during labour is the most effective method
for pain relief, but it appears to be associated with certain side
effects, such as maternal hypotension, decreased uteroplacental
perfusion, foetal bradycardia, fever, pruritus, an increased oxytocin
requirement, a prolonged second stage of labour, a higher rate of
operative delivery, and high costs.5–10 In contrast, many non-
pharmacological methods of pain relief appear to be safe, non-
invasive, easily applicable and inexpensive.2,11,12 They have few
contraindications and can postpone the use of pharmacological
analgesics and their associated adverse results.2,11,12 Furthermore,
many non-pharmacological methods of managing pain increase
the satisfaction of women with their childbirth experience. 2,11,12
Transcutaneous electrical nerve stimulation (TENS) is a non-
pharmacological method of labour analgesia that has been used for
over 30 years in European countries. Through electrodes applied to
the lower back, the parturient can control both the frequency and
intensity of the low-voltage electrical impulses emitted from thessociation. This is an open access article under the CC BY-NC-ND license (http://
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uncertain, although studies have shown that it has no harmful
effects on either the mother or the foetus.13–16 In current clinical
practice, TENS is used to reduce pain during the initial phases of
labour and to delay the need for pharmacological interventions.
Despite thewidespread use of TENS and its potential advantages for
the relief of labour pain, evidence from systematic reviews has been
inconsistent indemonstrating clearbeneﬁtsof thismethod.10,15,17 In
particular, theCochrane reviewof trials of TENSused in labour found
no information on the use of TENS in very early labour.15
Therefore, the research questions for this randomised trial
were:1. In the active phase of the ﬁrst stage of labour, does TENS relieve
pain or change its location?2. Does TENS delay the request for neuraxial analgesia during
labour?3. Does TENS produce any harmful effects in the mother or the
foetus?4. Are women in labour satisﬁed with the care provided?
Method
Design
This was a randomised trial with concealed allocation, assessor
blinding for some outcomes, and intention-to-treat analysis. The
principal investigator (LSS) randomly assigned the eligible women
to an experimental group or a control group, according to a
computer-generated random assignment list. When 4 cm of
cervical dilation and uterine contractions were achieved, the
principal investigator applied TENS continuously for 30 minutes to
the participants in the experimental group. A second investigator
(RBSG) remained blinded to group allocations and was never
present while the experimental or control procedures were
performed by the principal investigator and obstetricians of the
centre at which the study was conducted. The second investigator
recorded each participant’s responses regarding the pain severity
and location immediately before and after the intervention.
Blinding was maintained by having the second investigator leave
the room after assessing the pain-related outcomes at baseline and
returning to reassess the same outcomes after the intervention. All
participants were instructed not to make any comments regarding
the type of treatment that they received. After labour and before
hospital discharge, the second investigator collected the data
regarding obstetric and neonatal outcomes and also recorded the
opinion of the participants regarding the treatment that they
received during the study period.
Participants, therapists and centre
All participants were recruited from a group of women
admitted to the Reference Centre of Women’s Health of Ribeira˜o
Preto (MATER), state of Sa˜o Paulo, Brazil, from September 2011 to
January 2013. This is a 40-bed unit that serves approximately
3600 low-risk pregnant women per year in Brazil’s public health
system. The aim andmethodology of the studywas explained to all
recruited women and voluntary participation was requested.
The eligibility criteria included: primigravida parturientswith a
low-risk pregnancy; a gestational age > 37 weeks; a single foetus
in the cephalic position; spontaneous onset of labour; cervical
dilation of 4 cm; appropriate uterine contractions; intact ovular
membranes; no use of oxytocin or othermedications from hospital
admission until randomisation; and literacy, including the ability
to understand the study. Participants were free to withdraw from
the study if they could not tolerate the allocated intervention or if
they declined further participation at any stage.
The principal and secondary investigators involved in the
intervention and data collection were both physiotherapists andhadheld specialisations inwomen’s health since early 2008.During
the study, to reduce bias, the methods of pain assessment during
labour were standardised, and the therapists used the same
method for all participants. The principal investigator performed
the randomisation and the application of the interventions (TENS
or routine obstetric care), while the secondary investigator
assessed the outcomes.
Intervention
A portable TENS unita was used by the principal investigator to
apply the experimental intervention. Two pairs of electrodes
measuring 5 x 9 cm were ﬁxed on the paravertebral regions of the
participants of the experimental group using hypoallergenic
surgical tape. Two paired electrodes were placed 1 cm laterally
on either side of the spine at the T10 to L1 and S2 to S4 levels,
because these are the spinal levels that ultimately receive the
nociceptive information from the uterus, birth canal, and
perineum.18 [3_TD$DIFF] This group received TENS continuously for 30 minutes
starting at the beginning of the active phase of labour (4 cm of
cervical dilation). The TENS unit produces a modiﬁed biphasic
asymmetric pulse, and was set to a pulse width of 100 ms and a
frequency of 100 Hz. The intensity was individually titrated
according to the sensitivity of the parturient.
The principal investigator also attended participants in the
control group for 30 minutes at the beginning of the active phase of
labour, as performed for the experimental group, although the
investigator was present merely for observation and to answer
questions.
Participants in both groups received all other routine obstetric
care. In the centre in which the study was conducted, routine
obstetric care during the active phase of labour is based on the
recommendations of the World Health Organization.19 After
admission to the hospital, a meal was offered to the participants,
and resources for pain relief were permitted, if requested by the
participant. Such resources included a shower, bath, and neuraxial
labour analgesia. In addition, the participants were also instructed
to choose the most comfortable position. The presence of an
accompanying person was permitted during labour and delivery.
Outcome measures
Primary outcome
The primary outcomewas the change in pain severity at the end
of the intervention period. The instrument used to measure the
severity of pain before and after the intervention was the visual
analogue scale (VAS). In the VAS, pain severity is marked by the
participant on a scale with a range from 1 to 100 mm, in which
1 represents no pain and 100 represents the most painful situation
experienced. A change of 13 mm was nominated as a reduction in
acute pain that would be enough tomake the simple application of
TENS worthwhile.20,21
To qualitatively assess the pain experienced by the participants,
the classiﬁcation system described in the study by Jensen and
colleagues was used: 100-mm VAS ratings of 0 to 4 mm were
considered no pain; 5 to 44 mm,mild pain; 45 to 74 mm,moderate
pain; and 75 to 100 mm, severe pain.22
Secondary outcomes
The location and distribution of the pain were recorded using a
standard body diagram, which consisted of a simple graphical
representation of the front and back views of the human body. The
areas of pain were noted by the participant and marked on the
diagram by the second investigator.
The second investigator also collected obstetric and neonatal
outcomes. The obstetric outcomes included the duration of the
active phase of labour, time taken for the parturient to request
neuraxial labour analgesia after the end of the intervention period,
and mode of birth. The neonatal outcomes included the weight,
head circumference, chest circumference, and ﬁrst-minute and
Research 31ﬁfth-minute Apgar scores. Twenty-four hours postpartum, the
second investigator asked participants to answer questions
regarding their satisfaction with the care provided and if they
would prefer to receive the same type of care in the future.
The primary researcher recorded the posture adopted by each
participant during the intervention. More than one position could
be recorded.
Data analysis
After approval of the study by the ethics research committee, a
pilot study was conducted with 16 parturients to determine the
appropriate sample size. The objective of this test was to
determine the standard deviation of the pain severity on the
VAS. The goal was to power the study to detect an effect on pain of
approximately 13 mm. Using the standard deviation of 15 mm
obtained from the pilot data, a signiﬁcance level of 5% and a test
power of 80%, it was calculated that aminimumof 22 participants
were required for each group. Few dropouts were anticipated so
46participantswere recruited to allow for loss to follow-upof two
participants.
The values for each variable were summarised as mean (SD) or
number (%) as appropriate. For pain assessment, a comparative
analysis was performed between the experimental and control
groups using a linear regressionmodel withmixed effects (random
and ﬁxed effects). For dichotomous outcomes, the differences
between groups are presented as the relative risk with a 95% CI.
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Figure 1. Recruitment and ﬂow ofResults
Flow of participants and therapists through the study
The ﬂow of participants through the trial is shown in Figure 1. A
total of 283 parturients were assessed, and 237 who did not meet
the inclusion criteria were excluded. Forty-six participants were
included in the study and were enrolled into the two arms of the
study: the experimental group (n = 23) and the control group
(n = 23). Each participant received the intervention that was
randomly allocated to her. There was no loss to follow-up of
participants for any reason. No participant asked to leave the study
before completion.
The baseline characteristics of the participants in each group
are presented in Table 1. The groups were similar with regard to
maternal age, weight, height, body mass index, educational status,
marital status, presence of a person during labour, participation in
a childbirth preparation course, and uterine dynamics.
Effect of intervention
On the VAS of pain severity, the experimental group improved
by a mean of 11 mm (SD 18) from baseline [22_TD$DIFF]to the end of the
intervention. The control group showed a small increase in pain
intensity of [23_TD$DIFF]4 mm[24_TD$DIFF] (SD 16). Thus, the effect of TENS can be estimated
as –15 mm (95% CI –27 to –2 mm) on the VAS, as shown in
Table 2. When pain was qualitatively analysed by the VAS rating,
69% of the control group and 70% of the experimental groupControl group  
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participants through the trial.
Table 1
Baseline characteristics of the participants.
Characteristic Participants
Exp (n=23) Con (n=23)
Maternal age (y), mean (SD) range 20 (4) 18 to 21 20 (4) 18 to 21
Weight (kg), mean (SD) 71 (12) 71 (9)
Height (m), mean (SD) 1.59 (0.10) 1.61 (0.10)
BMI, mean (SD) 28.0 (3.9) 27.6 (3.3)
Skin colour, n (%)
Caucasian 14 (61) 13 (56)
other 9 (39) 10 (44)
Marital status, n (%)
single 10 (43) 7 (30)
with partner 13 (57) 16 (70)
Educational level (y), n (%)
 8 8 (35) 6 (26)
>8 15 (65) 17 (74)
Accompanying person during the
active phase of labour, n (%)
23 (100) 23 (100)
Childbirth preparation course 3 (13) 6 (26)
Uterine contractions at the moment of enrolment (n in 10 min), n (%)
2 7 (30) 6 (26)
3 13 (57) 15 (65)
4 3 (13) 2 (9)
BMI = body mass index, Exp = experimental group, Con = control group.
Santana et al: TENS reduces pain during labour32classiﬁed the pain as  7 before the intervention. After the
intervention, 34% of the experimental group rated the pain as  7,
as opposed to 83% of the control group, demonstrating a
statistically signiﬁcant reduction of pain during labour (RR 0.42,
95% CI 0.23 to 0.76). This result equates to a ‘number needed to
treat’ statistic (NNT) of 2 (95% CI 1 to 5), whichmeans that for every
two women treated with TENS, one will report pain as < 7 who
would otherwise have reported pain as  7.
An analysis of the pain location and distribution according to
the body diagram demonstrated that before the intervention, 18
(78%) parturients in the experimental group and 16 (70%) in the
control group reported pain both in the suprapubic and lumbar
regions. After the intervention period, 10 (43%) participants in the
experimental group and 15 (65%) in the control group reported
suprapubic and lumbar pain. Despite the apparent decrease in the
percentage of participants in the experimental groupwho reported
pain in those areas, no signiﬁcant between-group difference was
observed (RR 0.49, 95% CI 0.2 to 1.1).Table 2
Mean (SD) of groups, mean (SD) difference within groups, and mean (95% CI) differenc
Outcome Groups
0 min 30 min
Exp (n=23) Con (n=23) Exp (n=23) Co
Pain (mm) 68 (15) 69 (17) 57 (24)
Exp = experimental group, Con = control group.
Shaded row = primary outcome.
Table 3
Mean (SD) for each outcome in each group and mean difference (95% CI) between gro
Outcome
Duration of labour (hr), mean (SD)
Time from the end of the intervention until neuraxial analgesia was requested (hr), m
Newborn weight (kg), mean (SD)
Newborn length (cm), mean (SD)
Newborn head circumference (cm), mean (SD)
Newborn chest circumference (cm), mean (SD)
Exp = experimental group, Con = control group.The mean duration of labour was 6.5 hours (SD 2.3[2_TD$DIFF]) in the
experimental group and 5.7 hours (SD 1.5[2_TD$DIFF]) in the control group. The
mean difference was 0.8 hours, with no signiﬁcant difference
between groups (95% CI –0.3 to 2.0[2_TD$DIFF]). The mean time to neuraxial
analgesia after the end of the intervention was 7.0 hours (SD 1.7) in
the experimental group and 1.9 hours (SD 1.2) in the control group.
The mean between-group difference was 5.1 hours, which statisti-
cally signiﬁcant (95% CI 4.1 to 5.9). Therefore, TENS postponed the
need for pharmacological analgesia for pain relief during the active
phaseof labour.Theparturients in theexperimentalgroupweremore
likely to have adopted a left lateral decubitus position during the
intervention period than those in the control group (RR 10.0, 95% CI
1.4 to 72.0)[25_TD$DIFF]. [26_TD$DIFF] hese results are shown in Tables 3 and 4. For individual
participant data, see Table 5 on the eAddenda. Themode of birthwas
similar between the groups. The high rates of vaginal births in both
the experimental and the control groups are noteworthy, but the
groups did not differ signiﬁcantly (RR 1.1, 95% CI 0.8 to 1.4).
All anthropometric measures of the newborns are presented in
Tables 3 and 4. The mean newborn weight and head and chest
circumference were not signiﬁcantly different between groups.
The mean newborn weight was greater in the experimental group,
as opposed to the chest circumference, which was smaller than
that of the control group. In both groups, approximately 90% of the
newborns had Apgar scores > 7 by the ﬁrst minute after birth, and
all had normal scores by the ﬁfth minute after birth.
No signiﬁcant between-group differenceswere observed regard-
ing the labour experience and satisfaction with the care provided
during labour. Regarding the experience of the participants during
labour, 78% of the parturients in the experimental group and 74% of
the control group described it as terrible. However, all participants
stated that the quality of care provided by a physiotherapist during
labour was very important. The intervention was classiﬁed as
excellent by 74% of the participants in the experimental group and
70% in the controlgroup. Thosewomen reported relief ofpain, stress,
and anxiety during labour. All parturients in the experimental group
and94%of the control group stated that theywould prefer to receive
the same type of care during future childbirths.
Discussion
The results of this study have demonstrated that the use of TENS




30min minus 0 min 30min minus 0 min
n (n=23) Exp Con Exp minus Con
73 (15) –11 (18) 4 (16) –15 (–27 to –2)
ups for continuous obstetric and neonatal outcomes.
Groups Mean difference between groups
Exp [7_TD$DIFF]minus Con
Exp (n=23) Con (n=23)
6.5 (2.3) 5.7 (1.5) 0.8 (–0.3 to 2.0)
ean (SD) 7.0 (1.7) 1.9 (1.2) 5.1 (4.1 to 5.9)
3.2 (0.3) 3.2 (0.3) 0.1 (–0.1 to 0.3)
49.0 (1.5) 49.3 (1.7) –0.2 (–1.2 to 0.7)
34.4 (1.6) 34.6 (1.7) –0.2 (–1.2 to 0.8)
33.0 (1.3) 33.1 (1.6) –0.1 (–0.9 to 0.8)
Table 4
Number of participants (%) for each outcome in each group and relative risk (95% CI) between groups for
dichotomous obstetric and neonatal outcomes..
Outcome Groups Relative risk
(95% CI)
Exp (n = 23) Con (n = 23) Exp relative to Con
Position adopted during intervention, n (%)
sitting 8 (35) 10 (45) 0.8[8_TD$DIFF] (0.4 to 1.6)
lateral decubitus 10 (44) 1 (4) 10.0 [9_TD$DIFF] (1.4 to 72.0)
dorsal decubitus 4 (17) 9 (39) 0.44[10_TD$DIFF] (0.2 to 1.2)
sitting and dorsal decubitus 0 (0) 1 (4) NC
sitting and lateral decubitus 0 (0) 1 (4) NC
lateral and dorsal decubitus 1 (4) 1 (4) 1.0 [11_TD$DIFF] (0.1 to 15.0)
Path of delivery, n (%)
Caesarean delivery 2 (9) 4 (17) 0.5 [12_TD$DIFF] (0.1 to 2.5)
vaginal delivery 21 (91) 19 (83) 1.1[13_TD$DIFF] (0.8 to 1.4)
Apgar Score of newborn (0 to 10), n (%)
> 7 at ﬁrst minute 20 (87) 20 (87) 1.0 [11_TD$DIFF] (0.8 to 1.2)
> 7 at ﬁfth minute 23 (100) 23 (100) NC
Exp = experimental group, Con = control group, NC = not calculable.
Research 33decrease in pain. However, the application of TENS does not alter
the location or distribution of the pain. Beyond pain relief, this
study showed that the mean time until the participants requested
neuraxial labour analgesia after the end of the intervention was
greater in the experimental group, and no impact of the
intervention on maternal or neonatal outcomes was observed.
The ﬁndings of the present study are similar to those of previous
studies. Bundsen et al,23 [4_TD$DIFF] Van der Spank et al,13 and Chao et al14
reported a signiﬁcant reduction in pain intensity in the TENS
group. However, the methods of those studies are very different
from those of the present study. The Bundsen study included
patients undergoing induction of labour and receiving TENS at two
different locations simultaneously during labour. Van der Spank
et al adopted different TENS parameters. Chao et al investigated the
efﬁcacy of TENS in relieving pain during labour at speciﬁc
acupuncture points.
In contrast, controlled clinical trials have questioned the
effectiveness of TENS for pain relief during labour. Thomas et al24[5_TD$DIFF]
and Labrecque et al25 evaluated the impact of TENS applied to the
lower back and compared their results with those achieved with a
TENS placebo or no intervention. No signiﬁcant difference in pain
relief was found in any of the studies. A meta-analysis published by
Carroll et al17 showed conﬂicting results related to pain relief when
eight controlled clinical trials involving 712 women were analysed.
No signiﬁcant difference in pain relief was found, although three
studies noted improvements in secondary outcomes, such as a
reduction of additional analgesic interventions.Wepropose that the
discrepancies between the ﬁndings of those studies and the present
study could be explained by methodological differences between
the studies and by differences in obstetric care. Many studies had
small sample sizes, unbalanced groups, or various outcomes and
measurement scales for the assessment of pain.
Although several studies have not provided any evidence of
signiﬁcant differences in pain relief, many of their participants
have stated that they would prefer to use TENS for future labour. A
systematic review by Bedwell et al16 included 14 randomised,
controlled trials comparing women receiving TENS during labour
versus routine care or placebo devices. The authors demonstrated
little difference in satisfaction with pain relief or in pain ratings
between the TENS and control groups. However, approximately
two-thirds of womenwho received TENS reported that they would
prefer to use it again for future labour. In the present study, 74% of
the parturients in the experimental group reported being satisﬁed
with TENS, and 100% of them would prefer to use this method
again for future childbirths.
Few of the trials of TENS in labour have been conducted [28_TD$DIFF]with full
regard to the use of pharmacological analgesia, and most of them
have suggested no signiﬁcant differences in the ratio of women who
receive neuraxial analgesia in the control and experimental
groups.23,25–27[27_TD$DIFF] These data are similar to those obtained in the
present study. However, the present results also show that themeantime until pain medication was requested after the end of the
intervention was greater in the experimental group. Therefore, TENS
postponed the need for pharmacological analgesia for pain relief
during labour, asalsoobservedbydeOrangeetal.28However, readers
should be aware that de Orange et al deﬁned the time of
pharmacological pain relief as the time at which women reported
a pain level of 6 on the VAS.
In the present study, the mode of birth was similar between
groups. Unfortunately, most previous studies did not report
information on maternal and neonatal outcomes.15,16 Few studies
have founda lackof signiﬁcantdifferences betweengroups regarding
themodeofdelivery,asdemonstratedbythepresent results.23,25,28,29
A meta-analysis published by Bedwell et al16 included two studies
that reported information on foetal distress.23,28 No statistically
signiﬁcant between-group differences were observed. Ratna and
Rekha29 did not report any signiﬁcant differences between the Apgar
scores of neonates in their two experimental groups. Our results are
consistent with those that conﬁrm that TENS has no deleterious
effects on the foetus. These ﬁndings are also similar to those of the
Cochrane review performed by Dowswell et al.15[29_TD$DIFF]
Although the present study was a randomised trial in which the
random allocation of participants allowed for control of confound-
ing factors, some methodological limitations were still present.
The ﬁndings may have been more conclusive if TENS had been
applied for more than 30 minutes in the experimental group.
Furthermore, it was not possible to use a sham intervention in the
control group due to the difﬁculty of mimicking the sensory
stimulation promoted by TENS. However, providing words of
support may also generate placebo responses. Colloca and
Benedetti30 reported that the expectations associated with some
procedures could inﬂuence the responses to interventions, in both
positive and negative terms. Another limitation was the size of the
sample, which may have been insufﬁcient to determine the
relative risk of maternal and perinatal outcomes.
In conclusion, TENS administered at the beginning of the active
phase of labour produces a signiﬁcant decrease in pain and
postpones the need for pharmacological analgesia with no
deleterious maternal and perinatal effects. Therefore, it can be
considered an alternative and useful method for labour analgesia.What is already known on this topic: Pharmacological
analgesia during labour is effective, but it can have adverse
side effects. Transcutaneous electrical nerve stimulation
(TENS) is widely used for pain relief during labour, but a
systematic review indicates that the available trials of TENS
during labour do not clearly determine its effects.
What this studyadds:TENSadministered at the beginningof
the active phase of labour reduces pain and postpones the
need for pharmacological analgesia,with noharmful effects on
mother or neonate.
Santana et al: TENS reduces pain during labour34Footnotes: aKW National Industrial Electronic Technology Ltd,
Amparo, Sa˜o Paulo.
eAddenda: Table 5 can be found online at doi:10.1016/j.jphys.
2015.11.002
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